These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 15488780)

  • 1. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
    Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
    Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
    Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of intravitreal moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
    Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
    J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
    Asena L; Akova YA; Goktaş MT; Bozkurt A; Yaşar U; Karabay G; Demiralay E
    Curr Eye Res; 2013 Apr; 38(4):472-9. PubMed ID: 23373761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED; Comstock TL; Proksch JW
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
    Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
    Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
    Stewart WC; Crean CS; Zink RC; Brubaker K; Haque RM; Hwang DG
    Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
    Ong-Tone L
    J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.